AFG
ERNA icon

Allegheny Financial Group’s Eterna Therapeutics ERNA Stock Holding History

Allegheny Financial Group’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$2K – 172
2022
Q3 		$2K Hold
2
– – ﹤0.01% 162
2022
Q2 		$6K Hold
2
– – ﹤0.01% 166
2022
Q1 		$24K Hold
2
– – 0.01% 161
2021
Q4 		$48K Hold
2
– – 0.02% 157
2021
Q3 		$108K Buy
+2
New +$173K 0.05% 146

Other funds holding ERNA

NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
CPWM
Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Allegheny Financial Group's ERNA Position: Q4 2022 in Review

Allegheny Financial Group sold out of Eterna Therapeutics (ERNA) in Q4 2022, closing a stake of 2 shares — an estimated $2K sold.

Allegheny Financial Group first reported a position in ERNA in Q3 2021 and held it in 5 quarters. The position peaked at $108K in Q3 2021. 11 funds tracked by Wall St. Rank hold ERNA as of Q4 2022.

  • Allegheny Financial Group reported no remaining Eterna Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Allegheny Financial Group sold 2 Eterna Therapeutics shares in Q4 2022, an estimated $2K.
  • Allegheny Financial Group first reported a position in Eterna Therapeutics in Q3 2021 and held it in 5 quarters.
  • Allegheny Financial Group's Eterna Therapeutics position peaked at $108K in Q3 2021.
  • 11 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q4 2022.

Based on Allegheny Financial Group's 13F filing for Q4 2022, filed 8 Feb 2023.